Trials / Completed
CompletedNCT00079924
Effects of Teriparatide in Postmenopausal Women With Osteoporosis
Effects of Teriparatide in Postmenopausal Women With Osteoporosis Previously Treated With Alendronate or Raloxifene
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Effects of Teriparatide in Postmenopausal Women Previously Treated with Alendronate or Raloxifene.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | teriparatide | |
| DRUG | aldrenodate | |
| DRUG | raloxifene |
Timeline
- Start date
- 2004-11-01
- Completion
- 2007-05-01
- First posted
- 2004-03-19
- Last updated
- 2007-05-25
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00079924. Inclusion in this directory is not an endorsement.